Rapport Therapeutics, Inc. Common Stock
USD34.90
-2.21 (-5.96%)
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$36.32
Prev. Close
$37.11
Day Low
$34.44
Day High
$36.57
52W Low
$10.51
52W High
$42.27
Market Cap
$1.27B
Volume
0.30M
| 133,618 |
| $40.24 |
| 11 May 2026 | Third Rock Ventures V, L.P. | 10 percent owner | S-Sale | Disposed | 271,495 | $40.12 |
| 11 May 2026 | Third Rock Ventures V, L.P. | 10 percent owner | S-Sale | Disposed | 5,018 | $40.31 |
| 21 Apr 2026 | Third Rock Ventures V, L.P. | 10 percent owner | S-Sale | Disposed | 426,005 | $40.32 |
| 21 Apr 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | S-Sale | Disposed | 20,225 | $39.99 |
| 14 Apr 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | S-Sale | Disposed | 500 | $34.98 |
| 14 Apr 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | S-Sale | Disposed | 9,165 | $34.97 |
| 14 Apr 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | S-Sale | Disposed | 10,200 | $35.08 |
| 9 Apr 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | S-Sale | Disposed | 360 | $34.90 |